Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Nelson

Showing results (101-110 of 317) with videos related to

Pageof 32
Sort By:
Translational Psychiatry|March 4, 2020
Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 28, 2025
Basic Science and PathogenesisSandra O Tomé, Klara Gawor, Christine A F von Arnim, et al.
Acta Neuropathologica Communications|March 19, 2023
The localization of molecularly distinct microglia populations to Alzheimer's disease pathologies using QUIVERRyan K Shahidehpour, Abraham S Nelson, Lydia G Sanders, et al.
Acta Neuropathologica|November 24, 2016
Widespread tau seeding activity at early Braak stagesJennifer L Furman, Jaime Vaquer-Alicea, Charles L White, et al.
Translational Psychiatry|February 19, 2020
Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.
Brain Research|April 13, 2010
High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brainPeter T Nelson, Marianthi Kiriakidou, Zissimos Mourelatos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 19, 2024
Perspectives on the clinical use of anti-amyloid therapy for the treatment of Alzheimer's disease: Insights from the fields of cancer, rheumatology, and neurologyGregory A Jicha, Erin L Abner, Elif P Coskun, et al.
Experimental Gerontology|February 13, 2017
CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRNDavid W Fardo, Yuriko Katsumata, John S K Kauwe, et al.
Journal of Neuropathology and Experimental Neurology|September 23, 2011
Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought StudyKaren S SantaCruz, Joshua A Sonnen, Maryam Kherad Pezhouh, et al.
Experimental Neurology|January 7, 2015
Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injuryWang-Xia Wang, Nishant P Visavadiya, Jignesh D Pandya, et al.
Pageof 32

Showing results (101-110 of 317) with videos related to

Sort By:
Pageof 32
Translational Psychiatry|March 4, 2020
Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 28, 2025
Basic Science and PathogenesisSandra O Tomé, Klara Gawor, Christine A F von Arnim, et al.
Acta Neuropathologica Communications|March 19, 2023
The localization of molecularly distinct microglia populations to Alzheimer's disease pathologies using QUIVERRyan K Shahidehpour, Abraham S Nelson, Lydia G Sanders, et al.
Acta Neuropathologica|November 24, 2016
Widespread tau seeding activity at early Braak stagesJennifer L Furman, Jaime Vaquer-Alicea, Charles L White, et al.
Translational Psychiatry|February 19, 2020
Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's diseaseBalmiki Ray, Bryan Maloney, Kumar Sambamurti, et al.
Brain Research|April 13, 2010
High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brainPeter T Nelson, Marianthi Kiriakidou, Zissimos Mourelatos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 19, 2024
Perspectives on the clinical use of anti-amyloid therapy for the treatment of Alzheimer's disease: Insights from the fields of cancer, rheumatology, and neurologyGregory A Jicha, Erin L Abner, Elif P Coskun, et al.
Experimental Gerontology|February 13, 2017
CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRNDavid W Fardo, Yuriko Katsumata, John S K Kauwe, et al.
Journal of Neuropathology and Experimental Neurology|September 23, 2011
Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought StudyKaren S SantaCruz, Joshua A Sonnen, Maryam Kherad Pezhouh, et al.
Experimental Neurology|January 7, 2015
Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injuryWang-Xia Wang, Nishant P Visavadiya, Jignesh D Pandya, et al.
Pageof 32